We show that intranigral lipopolysaccharide (LPS) injection, which provokes specific degeneration of DA neurons, induced caspase-3 activation in the rat ventral mesencephalon, which was mostly associated with glial cells. In contrast, nigral DA neurons exhibited AIF nuclear translocation in response to LPS. A significant decrease of the Bcl-2/Bax ratio in nigral tissue after LPS injection was observed. We next developed an in vitro co-culture system with the microglial BV2 and the DA neuronal MN9D murine cell lines. The silencing of caspase-3 or AIF by small interfering RNAs exclusively in the DA MN9D cells demonstrated the key role of AIF in the LPS-induced death of DA cells. In vivo chemical inhibition of caspases and poly(ADP-ribose) polymerase-1, an upstream regulator of AIF release and calpain, proved the central role of the AIF-dependent pathway in LPS-induced nigral DA cell death. We also observed nuclear translocation of AIF in the ventral mesencephalon of Parkinson's disease subjects.
Introduction
Parkinson's disease (PD) affects approximately 1-3% of the population, and is characterised by a slow and progressive degeneration of dopaminergic (DA) neurons in the substantia nigra (SN) (Obeso et al., 2000) .
Recent evidence suggests that inflammation may play a central role in the cell loss seen in PD (Hirsch and Hunot, 2009; Tansey et al., 2007; Tansey and Goldberg, 2010) . Epidemiological studies have demonstrated convincingly that the incidence of idiopathic PD is lower in chronic users of anti-inflammatory drugs (Chen et al., 2003 (Chen et al., , 2005 Esposito et al., 2007) .
We have previously demonstrated that the intranigral injection of lipopolysaccharide (LPS) selectively induces the death of DA neurons (Castaño et al., 1998; Herrera et al., 2000) . Given the potential role of inflammation in the pathogenesis of PD, the elucidation of the cellular/molecular mechanisms leading to DA cell death in the LPS model is indispensable.
Studies in experimental models and PD patients are suggestive of multiple death pathways including intrinsic and extrinsic apoptosis and autophagy (Levy et al., 2009; Irrcher and Park, 2009) . Human postmortem studies suggest that DA neurons die by apoptosis in PD (Hartmann and Hirsch, 2001; Tatton et al., 2003) . Fas receptor (Mogi et al., 1996) and autophagic vacuoles (Anglade et al., 1997) were reported to be elevated within the nigrostriatal system of PD patients and in several experimental models of parkinsonism (Fornai et al., 2004) . Neural cell death associated with several PD genes, including α-synuclein, parkin, PINK1, DJ-1, and LRRK2, involves caspase activation (Levy et al., 2009) . Similarly, the DA neurotoxins MPTP, rotenone, and 6OHDA produce caspase activation and mitochondrial release of cytochrome c (Holtz et al., 2006; Sherer et al., 2002; Turmel et al., 2001) . However, the ability of caspase inhibitors to confer protection has been inconsistent (Bilsland et al., 2002; Chu et al., 2005; Hartmann et al., 2001; Liou et al., 2005; Lotharius et al., 1999; Yang et al., 2004) . This observation suggests that alternative death pathways, independent of caspase activation, can be activated in response to injury in nigrostriatal DA neurons. Neurobiology of Disease 41 (2011) 177-188 
